THC Drug Testing and Georgia Medical Cannabis Patients: What Your Card Does and Does Not Protect

Your Georgia medical cannabis card protects you from criminal prosecution for possession. It does not protect your job.

Georgia has no statute shielding registered patients from adverse employment action. An employer here may maintain a drug-free workplace policy, test for THC, and terminate or decline to hire you over a positive result, and your registry card is not a defense. For federally regulated and safety-sensitive workers the position is even more explicit: in May 2026, the Department of Transportation confirmed in writing that a state-issued medical cannabis card can never convert a laboratory-confirmed positive into a negative.

That makes understanding how THC testing actually works a practical necessity for Georgia patients, not a curiosity. The most important thing to understand is this: standard workplace drug tests do not measure impairment. They measure a metabolite that can persist for weeks after any effect has worn off.

This guide covers what each test type detects, realistic detection windows, why a positive result says nothing about whether you were impaired, where Georgia law leaves you, what federal rescheduling did and did not change, and how hemp products bought at a gas station can produce a positive test on their own.

Considering certification and worried about testing? Read this first, then talk to Elevated Health MD about your situation.

What THC Drug Tests Actually Measure

Most workplace tests do not look for THC. They look for THC-COOH, technically 11-nor-9-carboxy-THC, which is an inactive metabolite your liver produces as it breaks THC down.

That distinction drives everything else. THC-COOH is not psychoactive. It cannot make anyone impaired. It is fat-soluble, so it accumulates in adipose tissue and is released slowly over time, which is why cannabis has a detection window measured in days or weeks while alcohol clears in hours.

A positive urine screen therefore establishes one thing: that cannabinoids entered your body at some point within the detection window. It does not establish when, how much, or whether you were under the influence at the time of the test. This is well understood in toxicology and routinely misunderstood in workplaces.

How the two-stage process works

Stage one, the immunoassay screen. A rapid antibody-based test. Federal drug-free workplace programs use a cutoff of 50 ng/mL for marijuana metabolites. Non-federal employers and labs sometimes use 20 ng/mL or 100 ng/mL, which materially changes how long you remain positive.

Stage two, confirmatory testing. Any non-negative screen goes to GC-MS or LC-MS/MS, which identifies the specific metabolite and quantifies it. The federal confirmation cutoff is 15 ng/mL. Confirmatory testing is what eliminates cross-reactivity false positives from the screen.

A single screening result on its own should never be treated as final. If you are told you failed a test, ask whether it was confirmed.

Test Types and Detection Windows

Test type	What it detects	Typical detection window	Common use
Urine	THC-COOH metabolite	Days to weeks, depending heavily on use pattern	The default for workplace and DOT testing
Blood	Parent THC	Roughly 12 to 24 hours in occasional users, longer in frequent users	Traffic stops, post-accident investigation
Saliva	Parent THC	Roughly 13 to 26 hours	Roadside and some workplace programs
Hair	THC-COOH incorporated into the shaft	Up to about 90 days	Less common, poor at detecting occasional use

Blood is the closest thing to a recency test, but even it is unreliable as an impairment measure in regular users. One monitored-abstinence study found that 64% of chronic users had at least one THC-positive blood sample across seven days of supervised abstinence, with several still testing positive after a full week. Detection in a frequent consumer does not establish current impairment.

Hair testing is the longest window but the least useful for occasional use. Occasional consumers show substantially lower detection rates than daily users, and specificity limitations keep it out of most workplace programs.

Realistic Urine Detection Windows by Use Pattern

At the standard 50 ng/mL workplace cutoff:

• Single or occasional use. Typically one to three days, and it would be unusual to extend beyond three to four days.
• Moderate use, roughly weekly. Commonly five to seven days.
• Daily use. Commonly ten to fifteen days.
• Heavy, multiple-daily use. Can extend far longer. Reported outliers run past 30 days, with the longest documented cases considerably beyond that.

At a more sensitive 20 ng/mL cutoff, the windows lengthen substantially. A single use can register up to about seven days, and it would be uncommon for a chronic user to remain positive beyond about 21 days.

Individual variation is large. Body fat percentage, metabolic rate, liver function, hydration, and genetics all affect elimination. THC-COOH levels in habitual users can reach concentrations in the hundreds of ng/mL and then take three to five days after cessation just to fall into the 50 ng/mL range, remaining detectable well beyond that. Nobody can tell you your personal detection window with precision, and any source that offers a clean number is overselling.

This matters for Georgia patients specifically. Since SB 220 removed the 5% THC cap on July 1, 2026, products available through licensed dispensaries and pharmacies are considerably stronger than what the program offered before. A patient on a regular therapeutic regimen under the current framework should assume a longer detection window than the same patient would have had in 2024.

Where Georgia Law Leaves You

Flatly: with nothing.

Georgia has enacted no employment protection for medical cannabis patients. There is no accommodation requirement, no safety-sensitive carve-out with a general rule around it, and no cause of action for wrongful termination based on registry status. Employers may test, may act on results, and are not required to consider your card.

Georgia also offers employers a workers’ compensation premium discount for maintaining a qualifying drug-free workplace program, which is a direct financial incentive pushing Georgia employers toward testing rather than away from it.

If you work in healthcare, education, transportation, law enforcement, manufacturing, or any safety-sensitive role, treat this as the primary consideration before certifying. Our guide to the legal risks of a Georgia card covers the employment question alongside firearms, housing, and travel.

Federal and DOT Testing: The Card Is Explicitly Not a Defense

This is the most current and most important part of the picture, and it was settled in 2026.

When state-licensed medical cannabis moved from Schedule I to Schedule III in April 2026, drivers and safety-sensitive workers reasonably asked whether that changed anything for federal testing. In May 2026, the DOT’s Office of Drug and Alcohol Policy and Compliance issued an official Part 40 question and answer, jointly with the DOT Office of General Counsel, answering it directly.

The answer was no. Under 49 CFR 40.137(a) and 40.141(b), a Medical Review Officer must verify a confirmed positive unless the employee offers a legitimate medical explanation. ODAPC’s guidance states that there is currently no instance in which an MRO could verify a laboratory-confirmed marijuana positive as negative when the employee claims it came from a state-licensed product. The reasoning is that state-dispensed cannabis is not an FDA-approved drug, cannot be prescribed, and a legitimate medical explanation requires a legally prescribed controlled substance under federal law.

State medical cannabis cards, dispensary receipts, and physician recommendations do not qualify. That position predates rescheduling and was unaffected by it.

The practical consequences for a CDL holder are severe and unchanged: a verified positive is reported to the FMCSA Drug and Alcohol Clearinghouse, the driver is immediately removed from safety-sensitive functions, and cannot return until completing a Substance Abuse Professional evaluation and the return-to-duty process under 49 CFR 40.305 and 40.307. Clearinghouse records are visible to prospective employers conducting required queries.

If you hold a CDL or work in a DOT-regulated role, certification is very likely incompatible with your job. That is a conversation to have with an attorney before you book an evaluation, not after a random test.

Did Rescheduling Change Workplace Testing at All?

No, and this is worth stating plainly because the headlines suggested otherwise.

The April 2026 order moved two narrow categories to Schedule III: marijuana contained in an FDA-approved drug product, and marijuana subject to a qualifying state medical license. Everything else stayed in Schedule I. A scheduling change does not amend 49 CFR Part 40; DOT would have to change its own testing rule, and it has not. The five-panel test still includes marijuana. Cutoffs are unchanged. MRO verification practice is unchanged. Random selection, reasonable suspicion, post-accident, and return-to-duty procedures are all unchanged.

For private Georgia employers outside federal regulation, nothing changed either, because Georgia never had a protection to lose.

How Hemp and CBD Products Cause Unexpected Positives

This catches Georgia patients constantly, and it is worth understanding because it can produce a positive test in someone who has never purchased from a licensed dispensary.

Full-spectrum CBD contains THC. Hemp-derived products may contain up to 0.3% delta-9 THC by dry weight and still be legal hemp. That is a small percentage, but with regular use of a full-spectrum product it can accumulate enough to trigger a positive screen.

Delta-8 THC is not distinguished at the screening stage. Standard workplace immunoassays generally do not differentiate delta-8 metabolites from delta-9 metabolites. A delta-8 gummy from a smoke shop can register as a marijuana positive.

Retail hemp products are a different regulated market. In Georgia, intoxicating hemp products sold at gas stations and smoke shops fall under the Georgia Department of Agriculture’s hemp program, not under the Georgia Access to Medical Cannabis Commission. Different testing standards, different labeling requirements, and no registry protection extends to them even if you hold a card. Products have been found to contain more THC than the label states.

If you are subject to testing and you use CBD for any reason, understand what you are actually taking. Products labeled broad-spectrum or isolate carry less risk than full-spectrum, but label accuracy in the retail hemp market is inconsistent.

On secondhand smoke: under normal, well-ventilated conditions, passive exposure is unlikely to produce enough THC-COOH to exceed a 50 ng/mL cutoff. It is a real phenomenon under extreme, enclosed, prolonged conditions, but it is not a plausible explanation for a routine workplace positive.

What Georgia Patients Should Actually Do

Know your employer’s policy before you certify. Ask for it in writing. Policies vary widely between Georgia employers, and some do not test at all.

Do not assume disclosure helps. Telling an employer you hold a registry card gives them information without giving you protection, since Georgia provides none. Whether disclosure makes sense depends entirely on your employer and your role, and it is worth discussing with an employment attorney rather than guessing.

If you are DOT-regulated, get legal advice first. The ODAPC guidance above leaves no room for interpretation.

Read hemp labels, or avoid retail hemp entirely if you are subject to testing.

Ask whether a screen was confirmed. A non-negative immunoassay is not a final result.

Talk to your certifying physician about your work situation. Formulation, dose, and route affect accumulation, and a physician who knows you face testing can factor that into the conversation. That is a clinical discussion, not something to work out from a website.

Do not interpret a positive test as evidence you were impaired. It is not, and that distinction can matter in an administrative proceeding, though it will not by itself save a job in Georgia.

Before You Certify

For most Georgia patients with a qualifying condition, the employment question is the single largest factor in whether certification makes sense. It deserves an honest accounting rather than reassurance.

If you are in a role that does not test, or an employer whose policy you have read and can live with, the testing issue may be irrelevant to you. If you are in a federally regulated, safety-sensitive, or contractor role, it may be decisive. Neither answer is universal, and a certification service that does not raise the question with you is not doing its job.

Our guides to qualifying conditions and the benefits and drawbacks of a Georgia card cover the rest of the decision.

Get Started with Elevated Health MD

Elevated Health MD is a Georgia practice with Georgia-licensed physicians practicing in Georgia, which is the requirement that determines whether a provider can certify a Georgia patient at all.

We serve patients across Atlanta, Marietta, Chamblee, Gainesville, Macon, Columbus, Rome, and Savannah by telehealth. Part of an evaluation is a real conversation about your circumstances, including employment, because a patient who understands the tradeoffs makes a better decision than one who does not.

Get Started with Elevated Health MD

Not sure whether you qualify? Run our Do You Qualify screening or read our frequently asked questions.

Frequently Asked Questions

Does a Georgia medical marijuana card protect me from a drug test?

No. Georgia has no employment protections for medical cannabis patients. Employers may test for THC and take adverse action on a positive result, and your registry card is not a defense.

How long does THC stay in your system for a urine test?

At the standard 50 ng/mL workplace cutoff, roughly one to three days for a single use, five to seven days for weekly use, ten to fifteen days for daily use, and considerably longer for heavy multiple-daily use. At a more sensitive 20 ng/mL cutoff the windows lengthen substantially. Individual variation is large.

What are the federal drug test cutoffs for marijuana?

Federal drug-free workplace programs use a 50 ng/mL cutoff for the initial immunoassay screen and a 15 ng/mL cutoff for GC-MS or LC-MS/MS confirmatory testing. Non-federal employers sometimes use 20 or 100 ng/mL for the screen.

Does a positive THC test mean I was impaired at work?

No. Standard tests detect THC-COOH, an inactive metabolite that is not psychoactive and can persist for days or weeks after any effect has ended. A positive result establishes exposure within a window, not impairment at the time of testing.

Can a Medical Review Officer accept my Georgia card as an explanation for a DOT positive?

No. In May 2026 the DOT’s Office of Drug and Alcohol Policy and Compliance issued official Part 40 guidance stating there is currently no instance in which an MRO may verify a lab-confirmed marijuana positive as negative based on a state-licensed product. State cards, dispensary receipts, and physician recommendations do not constitute a legitimate medical explanation under 49 CFR 40.137(a).

Did the 2026 rescheduling change workplace drug testing?

No. A scheduling change does not amend 49 CFR Part 40. The five-panel test still includes marijuana, cutoffs are unchanged, and MRO verification practice is unchanged. Private Georgia employers were never restricted to begin with.

What happens if a CDL driver tests positive in Georgia?

The verified positive is reported to the FMCSA Drug and Alcohol Clearinghouse, the driver is removed from safety-sensitive functions immediately, and cannot return until completing a Substance Abuse Professional evaluation and the return-to-duty process. Clearinghouse records are visible to prospective employers.

Can CBD make me fail a drug test?

Yes. Full-spectrum hemp products may legally contain up to 0.3% delta-9 THC by dry weight, and regular use can accumulate enough to trigger a positive screen. Delta-8 THC is generally not distinguished from delta-9 at the screening stage either. Retail hemp in Georgia is regulated separately by the Department of Agriculture, and label accuracy is inconsistent.

Can secondhand cannabis smoke cause a positive test?

Under normal, well-ventilated conditions, passive exposure is unlikely to exceed the 50 ng/mL workplace cutoff. It is not a plausible explanation for a routine workplace positive.

Which drug test has the longest detection window?

Hair testing, at up to roughly 90 days, though it is poor at detecting occasional use and is uncommon in workplace programs. Urine has the most practically relevant window for employment testing.

Should I tell my employer I have a medical cannabis card?

That depends entirely on your employer, your role, and your policy, and Georgia gives you no protection either way. Disclosure provides information without conferring rights. Discuss it with an employment attorney rather than deciding from a website.

Does blood or saliva testing show current impairment?

Neither reliably establishes impairment in regular users. Blood detects parent THC for roughly 12 to 24 hours in occasional users but far longer in frequent users, and one study found 64% of chronic users had at least one positive blood sample during seven days of monitored abstinence.

Your card protects your possession. Protecting your job is a separate conversation, and Georgia has not had it yet. Get started.